Monthly Archives: January 2008

Doc Bans Drug Rep of Psoriasis Medicine

In May 2006, David Peng, a dermatology professor at the University of Southern California, was disturbed by claims made by an Amgen district manager, who was trying to boost Enbrel at the expense of an older psoriasis med, methotrexate. And so Peng banned Amgen reps from doing ‘lunch-in-learns’ with residents at his clinic at USC’s Keck School of Medicine, and decided to use a med by Genentech for an investigator-initiated study.We know this after reading an e-mail from an Amgen rep, Matt Mitchell, who was at the May 2006 sales call. He wrote this follow-up note to his manager: “During our call, he (Peng) expressed to me that the call you and I made on him in May really upset him. He took issue with some of the information you expressed to him about MTX: its safety and relative cost. He felt that the data was not properly represented. He stated that he has always had a lot of respect for Amgen and thinks that Enbrel is the best biologic. However, he thought that some of the claims you were making were not what he had come to expect from Amgen.”… Read Entire Story….

Do Epilepsy Drugs Increase Risk For Suicide?

The agency posted a warning on its web site this afternoon about an increased risk of suicidal thoughts and behaviors associated with 11 drugs used to treat epilepsy and certain psychiatric disorders. The drugs include Pfizer’s Lyrica, which is approved for treating pain associated with diabetes and fibromyalgia; Johnson & Johnson’s Topamax, which is also approved to treat migraines; and Glaxo’s Lamictal.“Patients who were treated for epilepsy, psychiatric disorders, and other conditions were all at increased risk for suicidality when compared to placebo, and there did not appear to be a specific demographic subgroup of patients to which the increased risk could be attributed. The relative risk for suicidality was higher in the patients with epilepsy compared to patients who were given one of the drugs in the class for psychiatric or other conditions,” the FDA wrote…..read entire story

Do Air Purifiers Work on Plane Trips?

By Robert Haru Fisher
January 2, 2008

You may have seen those odd-looking little black or gray things hanging around the necks of fellow air travelers. They are the size of a small matchbox or a really tiny MP3 player. The idea behind these “ionizers” is that they screen out particles from the air — perhaps even bacteria — that might otherwise cause the wearer allergies or head colds. The ads for some state they “protect against harmful airborne pollutants and germs” (AirTamer) or “reduce particles in the 0.04 to 3 micron range” (Fresh Air Buddy). I looked into four products for this article, three you wear around your neck and one you adhere over the air nozzle above you in the plane.

Some suppliers mention that their portable devices, such as the one I use, can be worn elsewhere than airplanes, in any crowded situation such as theaters, restaurants, offices, subways, trains and buses. That may be a good idea, especially during flu season…..Read Rest of Story

To Purchase the Wein Wearable Air Supply (identical to the Fresh Air Buddy), visit http://www.eHealthSupplies.com

MRSA Superbug Screens Urged For Hospitals

 MRSA, or Methicillin Resistant Staph Aureus is a bacteria  that is ubiquitous in communities throughout the USA.  In addition to schools, gyms and stores, it is also in hospitals.  Testing everyone who enters the hospital may not be  practical. As a matter of fact, patients with MRSA may  be  in  the majority.
———–
MRSA screens urged for hospitals

var requestedWidth = 0;

if(requestedWidth > 0){ document.getElementById(‘articleViewerGroup’).style.width = requestedWidth + “px”; document.getElementById(‘articleViewerGroup’).style.margin = “0px 0px 10px 10px”; } HARTFORD — Patient advocates and Attorney General Richard Blumenthal on Wednesday called for better monitoring to reduce rates of the deadly staph infection MRSA in state hospitals.In response, the Connecticut Hospital Association on Wednesday announced a series of attempts to prevent and control such infections, including a “pledge” that state hospitals will use to control methacillin-resistant staphylococcus aureus.

“There should be screening for MRSA whenever anybody at risk enters a hospital,” Blumenthal said, adding that “simple, common-sense” measures, such as more hand washing, can literally save lives.

“Thousands of people in Connecticut and 100,000 across the country die every year because of this disease,” he said. “It is totally and completely preventable.”

The legislation supported by Blumenthal and the nonprofit Connecticut Center for Patient Safety would require hospitals to screen cancer patients and those admitted to their intensive care units.

“Hospitals must be made safer,” he said. “I was struck in preparing this legislation that an enormous number of people become sick — from diseases that they did not go to the hospital to treat — while they were in the hospital.”

The legislation would also require annual reports to the Department of Public Health, detailing the number of patients who contracted MRSA infections.…. Read the rest of the story

Put Your Finger Where? Prostate Exams Critical-

Taking the test: Prostate exams are critical for men over 50

Knight Ridder/Tribune Business News

01-30-08

Jan. 29–For men over 50 years of age, the unpleasant prospect of prostate cancer is a fact of life.

While some make the decision to regularly undergo screening, others prefer not to worry about a test some experts say can be inaccurate or unnecessary.

But why all the fuss?

The prostate gland is a small organ in men, located behind the pubic bone, beneath the bladder and above the rectum.

According to the Centers for Disease Control: “Among the leading causes of cancer death in men, prostate cancer is second, behind lung cancer. When compared with all causes of death in men over age 45, prostate cancer ranks fifth.”

The CDC says the average man has about a one in six chance of being diagnosed with prostate cancer and a one in 33 chance of dying from the disease.

To combat the risk, approximately three-quarters of U.S. men over 50 undergo regular prostate exams, most commonly, the prostate-specific antigen (PSA) test and the digital rectal exam.

But some sources believe the tests are an imprecise method of diagnosing prostate cancer, and a cause for unnecessary concern for many patients.

In a 2006 study conducted at several Veterans Affairs hospitals in New England, out of approximately 72,000 men over 50, patients who had been screened for the disease weren’t any more likely to survive then those who were not.

Some doctors have argued the rectal exams can miss cancerous growths, and blood tests for PSAs may not reflect whether a problem exists or not.

Julie Finney, physicians assistant at NeoHealth Tahlequah, says men are better safe than sorry, and regular physical exams — especially the digital rectal exam — can reduce their risk of dying from prostate cancer.

“It’s the only thing that can tell us there is a problem,” said Finney. “A lot of our patients, especially the cash-paying clients, can’t afford the PSA tests. But a digital rectal exam is low cost and is a look at prevention, because we can feel the size and whether the prostate is enlarged, or if there are nodules.”

While the digital rectal exam is the preferred method, Finney said, both tests are meant to work as safeguards and used in conjunction with one another.

“It’s [digital rectal exam] part of a physical exam, just like looking at your eyes or in your ears,” Finney said. “The PSA is something that should be done in addition to. You would send them [the patient] for a PSA to verify if something was found, and if the PSAs are high, then you should probably send them for a biopsy.

“As far as accuracy, if you do an exam and you find an enlarged prostate or nodules that shouldn’t be there, there is an abnormality,” Finney said. “By finding it early, you have the time to get early treatment. I know it’s not a pleasant thing, but it’s extremely important — especially if there is a family history or if they are over 50.”

The good news for many men may be in the form of research findings recently published in the New England Journal of Medicine.

According to the study, American and Swiss scientists have identified several genetic markers that indicate risk factors in men with a family history of prostate cancer.

The new research, however, is acknowledged to be only a small step toward more dependable prostate screening, and men are better off being screened by the conventional method.

“I just think it’s such an easy thing to do once a year. It’s simply a measurement,” said Finney. Learn more

For more information on prostate cancer and screening call 1-800-4-CANCER (1-800-422-6237), or visit the Web site: www.healthfinder.gov and search for “prostate cancer.”

—–

To see more of the Tahlequah Daily Press or to subscribe to the newspaper, go to http://www.tahlequahdailypress.com/.

Copyright (c) 2008, Tahlequah Daily Press, Okla.

Distributed by McClatchy-Tribune Information Services.

For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Follow

Get every new post delivered to your Inbox.

Join 32 other followers